HILARY REZNICK: Open Payments
NPI 1902180656 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,783 in 153 payments from 23 companies in 2025. Trend: 2023 $2,775 · 2024 $3,022 · 2025 $2,783
Food & beverage: $2,701Education: $82
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 26 | $506 |
| GENZYME CORPORATION | 15 | $309 |
| ABBVIE INC. | 24 | $290 |
| Novartis Pharmaceuticals Corporation | 12 | $285 |
| Incyte Corporation | 12 | $219 |
| Regeneron Healthcare Solutions, Inc. | 9 | $203 |
| UCB, Inc. | 14 | $178 |
| Janssen Biotech, Inc. | 8 | $165 |
| PFIZER INC. | 6 | $100 |
| Lilly USA, LLC | 4 | $100 |
Products named: DUPIXENT, ADBRY, OPZELURA, SKYRIZI, COSENTYX, Bimzelx, TREMFYA, ANZUPGO.
Industry payments across AZ — which companies pay providers there.
